Optinadx
2 known investors
Optina develops a retinal imaging and AI platform, combining an FDA 510(k) cleared hyperspectral camera with AI to help eye specialists diagnose and manage Age-Related Macular Degeneration and other retinal disease. The platform supports early, intermediate, and late-stage detection, risk monitoring, and tracking of therapeutic effectiveness in at-risk patients.
AI & Machine LearningDigital HealthMedical Devices